OPK OPKO HEALTH, INC.

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

OPKO HEALTH, INC. (OPK) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 earnings announced Feb 26, 2026 — full results and financial guidance in Exhibit 99.1
• Conference call hosted to discuss Q4/FY2025 results plus forward business updates — guidance commentary is key investor focus

+1 more insights

Other OPKO HEALTH, INC. 8-K Filings

8-K Mar 19, 2026

Get deeper insights on OPKO HEALTH, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.